Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2014 1
2019 1
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
Freedland SJ, de Almeida Luz M, De Giorgi U, Gleave M, Gotto GT, Pieczonka CM, Haas GP, Kim CS, Ramirez-Backhaus M, Rannikko A, Tarazi J, Sridharan S, Sugg J, Tang Y, Tutrone RF Jr, Venugopal B, Villers A, Woo HH, Zohren F, Shore ND; EMBARK Study. Freedland SJ, et al. N Engl J Med. 2023 Oct 19;389(16):1453-1465. doi: 10.1056/NEJMoa2303974. N Engl J Med. 2023. PMID: 37851874 Clinical Trial.
The effectiveness of coronary computed tomography angiography and functional testing for the diagnosis of obstructive coronary artery disease: results from the individual patient data Collaborative Meta-Analysis of Cardiac CT (COME-CCT).
Schlattmann P, Wieske V, Bressem KK, Götz T, Schuetz GM, Andreini D, Pontone G, Alkadhi H, Hausleiter J, Zimmermann E, Gerber B, Shabestari AA, Meijs MFL, Sato A, Øvrehus KA, Jenkins SMM, Knuuti J, Hamdan A, Halvorsen BA, Mendoza-Rodriguez V, Rixe J, Wan YL, Langer C, Leschka S, Martuscelli E, Ghostine S, Tardif JC, Sánchez AR, Haase R, Dewey M. Schlattmann P, et al. Insights Imaging. 2024 Aug 14;15(1):208. doi: 10.1186/s13244-024-01702-y. Insights Imaging. 2024. PMID: 39143443 Free PMC article.
Global and regional quality of care index for prostate cancer: an analysis from the Global Burden of Disease study 1990-2019.
Nowroozi A, Roshani S, Ghamari SH, Shobeiri P, Abbasi-Kangevari M, Ebrahimi N, Rezaei N, Yoosefi M, Malekpour MR, Rashidi MM, Moghimi M, Amini E, Shabestari AN, Larijani B, Farzadfar F. Nowroozi A, et al. Arch Public Health. 2023 Apr 26;81(1):70. doi: 10.1186/s13690-023-01087-2. Arch Public Health. 2023. PMID: 37101304 Free PMC article.
We aimed to develop a metric for PCa quality of care that could demonstrate the disease's status in different countries and regions (e.g., socio-demographic index (SDI) quintiles) and assist in improving healthcare policies. ...These four indices were combined throu …
We aimed to develop a metric for PCa quality of care that could demonstrate the disease's status in different countries and regions ( …
Lack of beneficial effects of granulocyte colony-stimulating factor in patients with subacute myocardial infarction undergoing late revascularization: a double-blind, randomized, placebo-controlled clinical trial.
Karimabad HM, Shabestari M, Baharvand H, Vosough A, Gourabi H, Shahverdi A, Shamsian A, Abdolhoseini S, Moazzami K, Moradi Marjaneh M, Emami F, Bidkhori HR, Hamedanchi A, Talebi S, Farrokhi F, Jabbari-Azad F, Fadavi M, Garivani U, Mahmoodi M, Aghdami N. Karimabad HM, et al. Acta Cardiol. 2011 Apr;66(2):219-24. doi: 10.1080/ac.66.2.2071254. Acta Cardiol. 2011. PMID: 21591581 Clinical Trial.
G-CSF treatment was well tolerated in most patients and no major adverse cardiac events or severe G-CSF-related side effects were identified during hospitalization and at follow-up. No significant differences were observed between the G-CSF and placebo groups
G-CSF treatment was well tolerated in most patients and no major adverse cardiac events or severe G-CSF-related side effects w
A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice.
Hovakimyan A, Antonyan T, Shabestari SK, Svystun O, Chailyan G, Coburn MA, Carlen-Jones W, Petrushina I, Chadarevian JP, Zagorski K, Petrovsky N, Cribbs DH, Agadjanyan MG, Ghochikyan A, Davtyan H. Hovakimyan A, et al. Sci Rep. 2019 Oct 29;9(1):15455. doi: 10.1038/s41598-019-51809-2. Sci Rep. 2019. PMID: 31664089 Free PMC article.
Pathological tau correlates well with cognitive impairments in Alzheimer's disease (AD) patients and therefore represents a promising target for immunotherapy. ...
Pathological tau correlates well with cognitive impairments in Alzheimer's disease (AD) patients and therefore represents a promising …
Precision measurement of the neutron twist-3 matrix element d(2)(n): probing color forces.
Posik M, Flay D, Parno DS, Allada K, Armstrong W, Averett T, Benmokhtar F, Bertozzi W, Camsonne A, Canan M, Cates GD, Chen C, Chen JP, Choi S, Chudakov E, Cusanno F, Dalton MM, Deconinck W, de Jager CW, Deng X, Deur A, Dutta C, El Fassi L, Franklin GB, Friend M, Gao H, Garibaldi F, Gilad S, Gilman R, Glamazdin O, Golge S, Gomez J, Guo L, Hansen O, Higinbotham DW, Holmstrom T, Huang J, Hyde C, Ibrahim HF, Jiang X, Jin G, Katich J, Kelleher A, Kolarkar A, Korsch W, Kumbartzki G, LeRose JJ, Lindgren R, Liyanage N, Long E, Lukhanin A, Mamyan V, McNulty D, Meziani ZE, Michaels R, Mihovilovič M, Moffit B, Muangma N, Nanda S, Narayan A, Nelyubin V, Norum B, Nuruzzaman, Oh Y, Peng JC, Qian X, Qiang Y, Rakhman A, Riordan S, Saha A, Sawatzky B, Shabestari MH, Shahinyan A, Širca S, Solvignon P, Subedi R, Sulkosky V, Tobias WA, Troth W, Wang D, Wang Y, Wojtsekhowski B, Yan X, Yao H, Ye Y, Ye Z, Yuan L, Zhan X, Zhang Y, Zhang YW, Zhao B, Zheng X; Jefferson Lab Hall A Collaboration. Posik M, et al. Phys Rev Lett. 2014 Jul 11;113(2):022002. doi: 10.1103/PhysRevLett.113.022002. Epub 2014 Jul 11. Phys Rev Lett. 2014. PMID: 25062166
In this dedicated experiment, the spin structure function g(2)((3)He) was determined with precision at large x, and the neutron twist-3 matrix element d(2)(n) was measured at Q(2) of 3.21 and 4.32 GeV(2)/c(2), with an absolute precision of about 10(-5). ...
In this dedicated experiment, the spin structure function g(2)((3)He) was determined with precision at large x, and the neutron twist …
Recoil polarization measurements of the proton electromagnetic form factor ratio to Q2 = 8.5  GeV2.
Puckett AJ, Brash EJ, Jones MK, Luo W, Meziane M, Pentchev L, Perdrisat CF, Punjabi V, Wesselmann FR, Ahmidouch A, Albayrak I, Aniol KA, Arrington J, Asaturyan A, Baghdasaryan H, Benmokhtar F, Bertozzi W, Bimbot L, Bosted P, Boeglin W, Butuceanu C, Carter P, Chernenko S, Christy E, Commisso M, Cornejo JC, Covrig S, Danagoulian S, Daniel A, Davidenko A, Day D, Dhamija S, Dutta D, Ent R, Frullani S, Fenker H, Frlez E, Garibaldi F, Gaskell D, Gilad S, Gilman R, Goncharenko Y, Hafidi K, Hamilton D, Higinbotham DW, Hinton W, Horn T, Hu B, Huang J, Huber GM, Jensen E, Keppel C, Khandaker M, King P, Kirillov D, Kohl M, Kravtsov V, Kumbartzki G, Li Y, Mamyan V, Margaziotis DJ, Marsh A, Matulenko Y, Maxwell J, Mbianda G, Meekins D, Melnik Y, Miller J, Mkrtchyan A, Mkrtchyan H, Moffit B, Moreno O, Mulholland J, Narayan A, Nedev S, Nuruzzaman, Piasetzky E, Pierce W, Piskunov NM, Prok Y, Ransome RD, Razin DS, Reimer P, Reinhold J, Rondon O, Shabestari M, Shahinyan A, Shestermanov K, Sirca S, Sitnik I, Smykov L, Smith G, Solovyev L, Solvignon P, Subedi R, Tomasi-Gustafsson E, Vasiliev A, Veilleux M, Wojtsekhowski BB, Wood S, Ye Z, Zanevsky Y, Zhang X, Zhang Y, Zheng X, Zhu L. Puckett AJ, et al. Phys Rev Lett. 2010 Jun 18;104(24):242301. doi: 10.1103/PhysRevLett.104.242301. Epub 2010 Jun 18. Phys Rev Lett. 2010. PMID: 20873943
Among the most fundamental observables of nucleon structure, electromagnetic form factors are a crucial benchmark for modern calculations describing the strong interaction dynamics of the nucleon's quark constituents; indeed, recent proton data have attracted intense theor …
Among the most fundamental observables of nucleon structure, electromagnetic form factors are a crucial benchmark for modern calculations de …